Turn this role into an interview — a resume and cover letter built around what this employer wants.
Addition Therapeutics is seeking a dynamic Scientist/Senior Scientist to join the Bioanalytical Sciences team in South San Francisco. The role focuses on designing and executing in vitro, cell-based, and ex vivo assays to evaluate PRINT™-delivered payloads and assess pharmacology for preclinical translation.
You will contribute to translational studies across obesity and metabolic disease programs and collaborate across therapeutic technology development, pharmaceutical sciences, and preclinical
Addition Therapeutics is at the forefront of biotechnology innovation and is building the next generation of gene therapy using our proprietary PRINT™ (Programmable RNA-guided Integration Technology) platform. PRINT™ redefines genetic medicine by enabling development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome. Operating from state-of-the-art labs in South San Francisco, we are a Series A-stage company with programs across rare and common diseases.
We are looking for a dynamic and highly motivated Scientist / Senior Scientist to join our Bioanalytical Sciences team and contribute to the development and execution of various bioanalytical assays for preclinical translation and development. This is a hands-on research role: you will contribute directly to key translational studies that evaluate PRINT™-delivered payloads in disease-relevant contexts to generate high-quality data that guide candidate selection and advance therapeutic programs toward clinical development. The successful candidate will work across obesity and metabolic disease programs. They will have hands-on experience in preclinical drug development, particularly in developing and executing in vitro and ex vivo assays. They will be a highly collaborative and resourceful scientist with a keen interest in the translational efforts to bring the PRINT™ technology to the clinic for both rare and common diseases. This role has vast learning opportunities and interfaces with many key functional areas of the company including therapeutic technology development, pharmaceutical sciences, and preclinical translation. This role presents a unique opportunity to explore the multifaceted applications of PRINT™, paving the way for novel therapeutic programs that could redefine the landscape of genetic medicine.
The expected yearly salary for this position is $110,000-$130,000. Exact compensation may vary based on skills and experience.
We are an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.